Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Magnesium Sulfate in Pheochromocytoma Resection
NCT04320589Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine, magnesium sulfate in pheochromocytoma, sponsored by National Cancer Institute. Started Jun 2019; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
pheochromocytoma
Beyond the preview
Go deeper on NCT04320589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04320589.